<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of recurrent high-grade glioma</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of recurrent high-grade glioma</h1>
<div class="graphic"><div class="figure"><div class="ttl">Management of recurrent high-grade glioma</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">* Participation in clinical trials is encouraged.<br/>¶ Systemic therapy options include bevacizumab, bevacizumab plus chemotherapy (eg, nitrosoureas, temozolomide, irinotecan, carboplatin), and chemotherapy alone.<br/>Δ For glioblastoma; availability varies by region and center.<br/><font class="lozenge">◊</font> Implantation of carmustine wafers at the time of resection may be considered in selected patients (eg, those with contraindications to systemic therapy) but may affect eligibility for some clinical trials.<br/>§ Optimal candidates for reoperation are younger patients with large but well-circumscribed, symptomatic tumors that have recurred after an extended interval.</div><div id="graphicVersion">Graphic 97612 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
